News for 'US Generics'

Sun Pharma ends patent dispute with Actavis

Sun Pharma ends patent dispute with Actavis

Rediff.com6 Oct 2015

Ranbaxy, its partners and Actavis have signed a non-exclusive agreement.

Zydus infringed Takeda's patent, rules US court

Zydus infringed Takeda's patent, rules US court

Rediff.com20 Jun 2013

Takeda had filed a case of patent infringement in response to Zydus' abbreviated new drug application.

Indian drugmakers to pay higher facility fees on US hike

Indian drugmakers to pay higher facility fees on US hike

Rediff.com3 Aug 2014

The US laws authorise the drug and health watchdog to assess and collect user fees for certain applications and supplements for human generic drug products

Glenmark gets USFDA nod for drug

Glenmark gets USFDA nod for drug

Rediff.com19 Jun 2013

Riluzole is indicated for the treatment of amyotrophic lateral sclerosis.

Sun Pharma to buy Ranbaxy in $3.2-billion deal

Sun Pharma to buy Ranbaxy in $3.2-billion deal

Rediff.com7 Apr 2014

Sun Pharmaceutical said Ranbaxy shareholders will get 0.8 Sun Pharma shares for each Ranbaxy share.

Sun Pharma gets US trade regulator nod for Ranbaxy deal

Sun Pharma gets US trade regulator nod for Ranbaxy deal

Rediff.com2 Feb 2015

Ranbaxy was asked to sell all products containing Leuprorelin which are marketed and supplied under brand name Eligard.

Why Should Govt Be In Fintech?

Why Should Govt Be In Fintech?

Rediff.com15 Dec 2021

The temptation to get into businesses that are hot is perhaps too great for any politician, no matter what his public slogans are. Nehru plunged into hot sectors of his time -- engineering and iron and steel. Modi has plunged into digital payments -- the hot sector of his time, notes Debashis Basu.

How India's pharma growth story fizzled out

How India's pharma growth story fizzled out

Rediff.com5 Jul 2017

Once tipped to emerge as the biggest exporter, the pharmaceutical industry is yet to acquire the scale of those in software services, says Krishna Kant.

Lupin buys 30% in Aussie company

Lupin buys 30% in Aussie company

Rediff.com22 Aug 2008

The Melbourne-headquartered Generic Health markets generic prescription and over-the-counter products in the Australian market, in a partnership model with established global generic drug makers. The company sells approximately $500 million (nearly Rs 2,150 crore) worth of drugs in Australia, which has Rs 11,300 crore (A$3 billion) worth generics market. The total drug market in Australia is worth A$10 billion (Rs37,800 crore).

Are Indian drugs safe? US doctors worried over quality

Are Indian drugs safe? US doctors worried over quality

Rediff.com18 Mar 2014

Some US doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration.

Do you have a hospital cash benefit plan?

Do you have a hospital cash benefit plan?

Rediff.com4 Mar 2021

Make sure you read the policy wording. Some policies cover pre-existing diseases while others don't. Many need a minimum 24-hour hospitalisation, advises Bindisha Sarang.

4 Indian drug firms recall products in US market

4 Indian drug firms recall products in US market

Rediff.com15 Nov 2020

Indian drug firms like Marksans Pharma, Aurobindo Pharma, Zydus and Jubilant are recalling products in the US market, as per the latest enforcement report by the US Food and Drug Administration (USFDA). While Marksans Pharma is recalling diabetes drug, Zydus Pharmaceuticals (USA) is recalling drug which is used to reduce stomach acid. Similarly, Aurobindo Pharma (USA) is recalling pain relieving drug, while Jubilant Cadista is recalling a medication used to treat schizophrenia.

Sun Pharma sues Novartis in US court

Sun Pharma sues Novartis in US court

Rediff.com13 Jun 2013

In a development that could hasten the entry of the generic version of Gleevec into the US market, Indian drug major Sun Pharma has sued Novartis Pharmaceuticals Corp in the District Court of New Jersey, demanding rights to launch a generic version of the cancer drug before the Novartis patent expires.

Sun gets US trade regulator nod for Ranbaxy merger

Sun gets US trade regulator nod for Ranbaxy merger

Rediff.com1 Feb 2015

Torrent to buy Ranbaxy's anti-bacterial generic

'They didn't consider me for Freddy Mercury, at least they thought I could play Homi Bhabha'

'They didn't consider me for Freddy Mercury, at least they thought I could play Homi Bhabha'

Rediff.com31 Jan 2022

'What I love about Parsis is that we never take anything seriously.' 'Everyone's making fun of everyone.' 'So, they were like, 'Don't f*** it up, ch****!'.'

Glenmark gets nod for oral contraceptive tablets

Glenmark gets nod for oral contraceptive tablets

Rediff.com20 Jun 2011

United States Food and Drug Administration (USFDA) has given final approval to Glenmark Generics Inc for their abbreviated new drug application (ANDA) for Norgestimate and Ethinyl Estradiol tablets USP in the strengths of 0.18 mg/0.035 mg, 0.215 mg/0.035 mg and 0.25/0.035 mg, the company said in a statement.

'80-90% of real estate developers will shut down'

'80-90% of real estate developers will shut down'

Rediff.com1 Jun 2017

'And the top 10 per cent will grow because they have to serve the market.'

Pujara was victim of racism at Yorkshire

Pujara was victim of racism at Yorkshire

Rediff.com5 Dec 2020

Was called 'Steve', a racist reference to people of colour, reveals former staff

Interest rate: RBI to be on a long-pause on sticky non-food inflation: Report

Interest rate: RBI to be on a long-pause on sticky non-food inflation: Report

Rediff.com6 Jan 2021

The non-food component in the price basket will continue to keep inflation at a high level and result in a "long pause" in interest rates, a foreign bank said on Wednesday. The central bank is likely to pare the pandemic-driven emergency response as well, the report by Singaporean lender DBS said. It can be noted that the high inflation driven by the food prices has forced the RBI to go for a status quo in rates for the three consecutive reviews of the bi-monthly policy meetings, even as growth continues to be in the negative territory.

Dilip Shangvi down Rs 90,840 crores in two years!

Dilip Shangvi down Rs 90,840 crores in two years!

Rediff.com8 Jun 2017

An end to Sun Pharma founder Dilip Shanghvi's woes are not in sight.

Dr Reddy's buys 8 US drugs from Teva, Allergan for $350 million

Dr Reddy's buys 8 US drugs from Teva, Allergan for $350 million

Rediff.com13 Jun 2016

The combined sales of the branded versions of the products in the US is about $3.5 billion.

Heads Rolled, But Buck Stopped

Heads Rolled, But Buck Stopped

Rediff.com8 Jul 2021

The BJP ignored the principle of the Cabinet's joint responsibility and the adage of the buck stopping at the top, observes Amulya Ganguli.

Sun Pharma gets USFDA nod for anti-cancer injection

Sun Pharma gets USFDA nod for anti-cancer injection

Rediff.com5 Feb 2013

This generic Doxorubicin HCl Liposome injection USP, 2 mg/ml is therapeutically equivalent to Doxil Liposome Injection, 2 mg/ml of Janssen Research and Development, LLC.

Sun Pharma gets USFDA nod for epilepsy drug

Sun Pharma gets USFDA nod for epilepsy drug

Rediff.com17 Jun 2010

Drug maker Sun Pharmaceutical Industries on Thursday said it has received the US health regulator's nod for marketing a generic version of the Keppra injection, used for treating epilepsy, in the American market.

Cabinet nods Rs 15,000 cr scheme for pharma sector

Cabinet nods Rs 15,000 cr scheme for pharma sector

Rediff.com24 Feb 2021

The government on Wednesday approved a production-linked incentive (PLI) scheme for the pharmaceutical sector, entailing an outlay of Rs 15,000 crore. The Union Cabinet, chaired by Prime Minister Narendra Modi, approved the scheme which will benefit domestic manufacturers, help create employment and is expected to contribute to the availability of a wider range of affordable medicines for consumers. The duration of the scheme would be from 2020-21 to 2028-29 and is expected to promote the production of high value products in the country and increase the value addition in exports, an official release said.

Biocon inks pact with Mylan

Biocon inks pact with Mylan

Rediff.com14 Feb 2013

The Bengaluru-based firm has entered into a definitive agreement with Mylan for an exclusive strategic collaboration for the global development and commercialisation of generic versions of its three insulin analog products, Biocon Ltd said in a statement.

Sun Pharma in talks to buy Meda for $5-$6 billion

Sun Pharma in talks to buy Meda for $5-$6 billion

Rediff.com31 May 2013

Acquisition to boost its generics business in developed markets.

SPECIAL: Why the govt must streamline its free medicines plan

SPECIAL: Why the govt must streamline its free medicines plan

Rediff.com30 May 2013

A few states are already running their own schemes for providing free drugs from the government health centres.

Prices of 1,000 pharma brands to crash

Prices of 1,000 pharma brands to crash

Rediff.com29 Sep 2006

Prices may drop by up to 92 per cent with the pharma industry agreeing to a government proposal on capping trade margins.

Malaria drug: Glenmark settles dispute with GSK

Malaria drug: Glenmark settles dispute with GSK

Rediff.com12 Apr 2010

Glenmark Generics Inc has settled the litigation pending between the company and GSK over patent actions concerning atovaquone and proguanil hydrochloride 250mg/100mg tablets, the generic version of GSK's Malarone tablets, Glenmark Pharma said.

Benefit of Ranbaxy deal to accrue in few years: Sun Pharma

Benefit of Ranbaxy deal to accrue in few years: Sun Pharma

Rediff.com29 Sep 2014

The proposed acquisition is expected to close by the end of 2014, subject to approvals from Indian Courts and the anti-trust body in India and the US

Sun gets nod to sell anti-anxiety drug in US

Sun gets nod to sell anti-anxiety drug in US

Rediff.com18 Jun 2010

Sun Pharmaceutical Industries on Friday said that it has received the US Food and Drug Administration's nod to market a generic version of alprazolam, an anti-anxiety drug, in the US market.

Ministries clash over cap on foreign stakes in drug firms

Ministries clash over cap on foreign stakes in drug firms

Rediff.com28 Nov 2013

The finance ministry is resisting pressure from other departments to cap foreign ownership of domestic drugmakers, fearing such a move would discourage potential investors, a senior ministry source said.

Dr Reddy's sells US facility to UAE-based Neopharma

Dr Reddy's sells US facility to UAE-based Neopharma

Rediff.com2 Oct 2018

The plant and associated facilities focus on manufacturing or packaging Amoxicilin-based products, which include semi-synthetic penicillin

Anti-Covid drug developed by DRDO cleared for emergency use

Anti-Covid drug developed by DRDO cleared for emergency use

Rediff.com8 May 2021

It said clinical trials of the drug 2-deoxy-D-glucose (2-DG) showed that it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.

PM slams previous govts for not fulfilling promises

PM slams previous govts for not fulfilling promises

Rediff.com17 Apr 2017

He said that when he became the prime minister, he realised that it is the duty of the Centre and not the states to hand over land rights to the tribals.

FDA hikes fee for drug approvals, cuts unit inspection charge

FDA hikes fee for drug approvals, cuts unit inspection charge

Rediff.com5 Aug 2015

The fees for facility inspection of foreign companies have been reduced

Glenmark to conduct trials of potential COVID-19 drug

Glenmark to conduct trials of potential COVID-19 drug

Rediff.com30 Apr 2020

As per the clinical trial protocol approved, 150 subjects with mild to moderate COVID-19 will be randomised in the study in a 1:1 ratio to Favipiravir with standard supportive care or standalone standard supportive care. Treatment duration is a maximum of 14 days and the total study duration will be a maximum for 28 days from randomisation.

US drug regulator finds Indian companies critically ill

US drug regulator finds Indian companies critically ill

Rediff.com24 Sep 2013

The country's drug companies have attracted the highest number of enforcements from the American drug regulator in 2013, a year that has seen the US Food and Drug Administration turning stricter to ensure compliance levels and quality of medicines.

'Modi must resist US pressure on drug patents'

'Modi must resist US pressure on drug patents'

Rediff.com30 Sep 2014

Western drugmakers, including Pfizer Inc, Novartis AG, Roche Holding AG and Sanofi SA, covet a bigger share of the fast-growing Indian drugs market.